How the mistakes and successes of Canadian cannabis legalization serve as an example for other countries

Companies located in Argentina, Chile, Uruguay, and the United States are facing a new type of crime: the theft of cannabis plants. Pablo Fazio discusses the risks of this new trend in his column.

Clinical research suggests improvement in pain perception and emotional symptoms

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

New measures aim to expand access to treatments, train professionals, and adjust adult use regulations to combat the informal market

Interim decision ensures the commercialization of oils and extracts until May 2026 and prevents economic losses to the sector

Argentinian government decrees promote administrative changes in the state structure, keeping the legislation on medicinal cannabis in the country in force

Research supported by the Japanese government indicates that cannabis use occurs after alcohol and tobacco and rarely leads to the consumption of other substances

After the departure of Daniel Radío, the Uruguayan government selects Rodríguez to take on the leadership role at IRCCA

Associations question the exclusivity of dispensing in hospitals provided for in the new Royal Decree; deadline for defining clinical uses by the regulatory agency expired in early January

Main meeting point for the Medicinal and Industrial Cannabis industry in Latin America starts at 4pm

Learn how small changes can minimize harm and promote a healthier experience when consuming cannabis

Burnout has affected many professionals, but above all, medical communities.

In his debut column for Sechat, veterinarian Erik Amazonas evaluates the latest statement issued by the Federal Council of Veterinary Medicine (CFMV) regarding the prescription of cannabis-derived products.

Through dialogue, the entities seek to regulate associative cultivation for medicinal purposes in Brazil

Study indicates possible increases in cancer chances but acknowledges limitations in the research conducted

Ministry of Health extends deadline to avoid treatment interruptions in 2026; industry demands permanent law already validated by the EU

Ministry of Health and Anvisa claim technical complexity and propose a new schedule that extends until March 2026 to define the rules

The Ministry of Health of Panama has established the conditions for the exemption of finished cannabis products for therapeutic use, overcoming a long regulatory impasse

Recommendation from CNDH to the Government advocates for the inclusion of cannabis therapy in high-cost programs and the creation of specialized centers in the public health system